Tilray Brands, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Tilray Brands, Inc. (TLRY) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $20.64 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2021-05-10
- Tilray Brands, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2021-03-31 was $20.64M.
- Tilray Brands, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2020-12-31 was $7.59M, a 35.46% decline year-over-year.
- Tilray Brands, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2020-09-30 was -$1.88M, a 126.54% decline year-over-year.
- Tilray Brands, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2020-06-30 was -$12.81M.
- Tilray Brands, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2020 was -$10.27M, a 136.30% decline from fiscal 2019.
- Tilray Brands, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2019 was $28.30M, a 200.50% increase from fiscal 2018.
- Tilray Brands, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2018 was $9.42M, a 877.99% increase from fiscal 2017.
- Tilray Brands, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2017 was $963.00K, a 70.44% increase from fiscal 2016.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2021-03-31 | $20.64M 10-Q · filed 2021-05-10 | $28.24M derived: sum of 2 quarters · filed 2021-05-10 | $26.36M derived: sum of 3 quarters · filed 2021-05-10 | $13.54M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2020-12-31 | $7.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $5.71M derived: sum of 2 quarters · filed 2021-02-19 | -$7.10M derived: sum of 3 quarters · filed 2021-02-19 | -$10.27M 10-K · filed 2021-02-19 | ||
| 2020-09-30 | -$1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$14.69M derived: sum of 2 quarters · filed 2020-11-09 | -$17.86M 10-Q · filed 2020-11-09 | -$6.10M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2020-06-30 | -$12.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$15.98M 10-Q · filed 2020-08-10 | -$4.22M derived: sum of 3 quarters · filed 2021-05-10 | $2.87M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2020-03-31 | -$3.17M 10-Q · filed 2021-05-10 | $8.59M derived: sum of 2 quarters · filed 2021-05-10 | $15.68M derived: sum of 3 quarters · filed 2021-05-10 | $13.47M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $11.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $18.85M derived: sum of 2 quarters · filed 2021-02-19 | $16.64M derived: sum of 3 quarters · filed 2021-02-19 | $28.30M 10-K · filed 2021-02-19 | $28.21M 10-K · filed 2020-03-02 | |
| 2019-09-30 | $7.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $4.88M derived: sum of 2 quarters · filed 2020-11-09 | $16.54M 10-Q · filed 2020-11-09 | $20.43M derived: sum of 4 quarters · filed 2021-02-19 | ||
| 2019-06-30 | -$2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $9.45M 10-Q · filed 2020-08-10 | $9.45M 10-Q · filed 2019-08-13 | $13.34M derived: sum of 3 quarters · filed 2021-02-19 | $17.22M derived: sum of 4 quarters · filed 2021-02-19 | |
| 2019-03-31 | $11.66M 10-Q · filed 2020-05-11 | $15.55M derived: sum of 2 quarters · filed 2021-02-19 | $19.43M derived: sum of 3 quarters · filed 2021-02-19 | $20.93M derived: sum of 4 quarters · filed 2021-02-19 | ||
| 2018-12-31 | $3.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $7.77M derived: sum of 2 quarters · filed 2021-02-19 | $9.27M derived: sum of 3 quarters · filed 2021-02-19 | $9.42M 10-K · filed 2021-02-19 | ||
| 2018-09-30 | $3.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $5.38M derived: sum of 2 quarters · filed 2019-11-13 | $5.53M 10-Q · filed 2019-11-13 | $5.46M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $1.65M 10-Q · filed 2019-08-13 | $1.59M 10-Q · filed 2018-08-29 | $1.59M derived: sum of 3 quarters · filed 2020-03-02 | $1.59M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | $148.00K 10-Q · filed 2019-05-15 | $84.00K derived: sum of 2 quarters · filed 2020-03-02 | $82.00K derived: sum of 3 quarters · filed 2020-03-02 | |||
| 2017-12-31 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$66.00K derived: sum of 2 quarters · filed 2020-03-02 | $963.00K 10-K · filed 2020-03-02 | |||
| 2017-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $1.03M 10-Q · filed 2018-11-14 | ||||
| 2017-06-30 | $1.03M 10-Q · filed 2018-08-29 | |||||
| 2016-12-31 | $565.00K 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |